MaxLinear (NYSE: MXL ) reported earnings on April 30. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), MaxLinear met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly. Non-GAAP earnings per share grew. GAAP loss per share dropped.
Margins expanded across the board.
MaxLinear booked revenue of $26.5 million. The five analysts polled by S&P Capital IQ wanted to see a top line of $26.5 million on the same basis. GAAP reported sales were 28% higher than the prior-year quarter's $20.7 million.
EPS came in at $0.07. The five earnings estimates compiled by S&P Capital IQ averaged $0.03 per share. Non-GAAP EPS were $0.07 for Q1 compared to -$0.06 per share for the prior-year quarter. GAAP EPS were -$0.07 for Q1 versus -$0.20 per share for the prior-year quarter.
For the quarter, gross margin was 63.0%, 300 basis points better than the prior-year quarter. Operating margin was -8.3%, much better than the prior-year quarter. Net margin was -8.7%, much better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $28.3 million. On the bottom line, the average EPS estimate is $0.05.
Next year's average estimate for revenue is $118.8 million. The average EPS estimate is $0.30.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 19 members out of 28 rating the stock outperform, and nine members rating it underperform. Among eight CAPS All-Star picks (recommendations by the highest-ranked CAPS members), six give MaxLinear a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MaxLinear is buy, with an average price target of $9.33.
Is MaxLinear the best semiconductor stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add MaxLinear to My Watchlist.